MIRM Kronos AI forecast
A 30-trading-day price forecast for Mirum Pharmaceuticals Inc. (MIRM) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Mirum Pharmaceuticals Inc. at $98.80 on 2026-12-08, +15.5% from the last close of $85.56 on 2026-10-27. Eight out of ten sampled paths end between $94.43 and $101.43, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of MIRM
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $85.04 | $82.83 | $90.38 |
| 2026-11-10 | $86.39 | $84.68 | $89.66 |
| 2026-11-17 | $90.92 | $87.67 | $92.88 |
| 2026-11-24 | $92.43 | $88.08 | $95.38 |
| 2026-12-01 | $94.99 | $90.95 | $99.22 |
| 2026-12-08 | $98.80 | $94.43 | $101.43 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for MIRM?
- Kronos AI's median forecast for MIRM is $98.80 in 30 trading days, +15.5% from the last close, with a 10–90% range of $94.43 to $101.43.
- Is the MIRM Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC